Picture of Vyant Bio logo

VYNT — Vyant Bio News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapNeutral

Brief: Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-The-Market Under Nasdaq Rules

Feb 10 (Reuters) - Cancer Genetics Inc  CGIX.O :
    * CANCER GENETICS ANNOUNCES $17.5 MILLION COMMON STOCK
OFFERING
PRICED AT-THE-MARKET UNDER NASDAQ RULES
    * CANCER GENETICS INC - ISSUED 2,777,778 SHARES OF ITS
COMMON
STOCK AT A PURCHASE PRICE OF $6.30 PER SHARE

Source text for Eikon:  ID:nGNX2GkYKg 
Further company coverage:  CGIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Vyant Bio

See all news